Microvesicular Liver Graft Steatosis as a Risk Factor of Initial Poor Function in Relation to Suboptimal Donor Parameters

Transplantation Proceedings

Volumn 41, Issue 8, 2009, Pages 2985-2988

  Cieslak B ^a   Lewandowski, Z ^a   Urban, M ^a   Ziarkiewicz Wroblewska B ^a   Krawczyk, M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; PROTHROMBIN;

ARTICLE; BODY MASS; CONTROLLED STUDY; FATTY LIVER; HEART ARREST; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CHILD; FATTY LIVER; GRAFT SURVIVAL; HEART ARREST; HUMANS; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LIVER TRANSPLANTATION; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TISSUE DONORS;

EID: 70350490145     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.08.019     Document Type: Article

References (9)

1. Burt E.M. Nonalcoholic steatohepatitis definition and pathology. Semin Liver Dis 21 (2001) 3
2. Caldwell S.H., Oelsner D.H., Lezzoni J.C., et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29 (1999) 664
3. Hałoń A., Patrzałek D., and Rabczyński J. Hepatic steatosis In liver transplant donors: rare phenomenon or common feature of donor population?. Transplant Proc 38 (2006) 193
4. Attia M., Silva M.A., and Mirza D.A. The marginal liver donor-an update. Transplant Int 21 (2008) 713
5. D'Alessandro A.M., Kayaloglu M., Sollinger H.W., et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 51 (1991) 157
6. Fishbein T.M., Fiel M.I., Emere S., et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 64 (1997) 248
7. Zamboni F., Franchello A., David E., et al. Effect of macrovesicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 15 (2001) 53
8. Busuttil R.W., and Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 9 (2003) 651
9. Young K.F., Gunson B.K., Neil D.A.H., Mirza D.A., et al. Impact of Donor Liver Microvesicular Steatosis in the Outcome of Liver Retransplantation. Transplant Proc 31 (1999) 551